Citadel Advisors »

Xenon Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $66M 1.4M 46.06
2023-09-30 $26M 765k 34.16
2023-06-30 $20M 519k 38.50
2023-03-31 $33M 917k 35.79
2022-12-31 $48M 1.2M 39.43
2022-06-30 $51M 1.7M 30.42
2022-03-31 $45M 1.5M 30.57
2021-12-31 $42M 1.3M 31.24
2021-09-30 $18M 1.2M 15.28
2021-06-30 $20M 1.1M 18.61
2021-03-31 $4.0M 223k 17.90
2020-12-31 $1.1M 72k 15.38
2020-09-30 $3.5M 312k 11.07
2020-06-30 $4.9M 390k 12.54
2020-03-31 $5.7M 506k 11.34
2019-12-31 $3.0M 232k 13.11
2019-09-30 $2.5M 272k 9.01
2019-06-30 $4.3M 438k 9.86
2019-03-31 $6.6M 652k 10.16
2018-12-31 $5.3M 838k 6.31
2018-09-30 $12M 754k 15.62